Genetics and environmental factors in gastric carcinogenesis;Fatores genéticos e ambientais envolvidos na carcinogênese gástrica

Arquivos de Gastroenterologia

Volumn 39, Issue 4, 2002, Pages 253-259

  César, Ana Cristina Gobbo ^a   Silva, Ana Elizabete ^a,b   Tajara, Eloiza Helena ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE   (Brazil)

Author keywords

Genetics; Stomach neoplasms

Indexed keywords

CARCINOGENESIS; CHROMOSOME; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; GASTRITIS; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; MOLECULAR GENETICS; ONCOGENE; REVIEW; STOMACH CARCINOMA; TUMOR CELL; ADENOCARCINOMA; CELL TRANSFORMATION; CHROMOSOME ABERRATION; GENETICS; MUTATION; PATHOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; HUMANS; MUTATION; STOMACH NEOPLASMS;

EID: 18244425199     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032002000400009     Document Type: Review

References (71)

1. AICR - American Institute for Cancer Research. World Cancer Research Fund. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: Banta Book Group; 1997.
2. Anand BS, Graham DY. Ulcer and gastritis. Endoscopy 1999;31:215-25.
3. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-7.
4. Blanco R, Lyda M, Davis B, Kraus M, Fenoglio-Preiseer C. Trisomy 3 in gastric lymphomas of extranodal marginal zone-B cell (mucosa-associated lymphoid tissue) origin demonstrated by FISH in intact paraffin tissue sections. Human Pathol 1999;30:706-11.
5. Brien TP, Depowski MD, Sheehan CE, Ross JS, McKenna BJ. Prognostic factors in gastric cancer. Mod Pathol 1998;11:870-7.
6. Buonsanti G, Calistri D, Padovan L. Microsatellite instability in intestinal- and diffuse-type gastric carcinoma. J Pathol 1997;182:167-73.
7. Cahill RJ, Xia H, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995;40:1627-31.
8. Chan AO, Lam SK, Chu KM, Lam CM, Kwok E, Leung SY, Yuen ST, Law SY, Hui WM, Lai KC, Wong CY, Hu HC, Lai CL, Wong J. Soluble E-cadherine is a valid prognostic marker in gastric carcinoma. Gut 2001;48:808-11.
9. Cheli R, Giacosa A. Atrophic gastritis. In: Sherlock P, Morson BC, Barbara L, Veronesi U. editors. Precancerous lesions for the gastrointestinal tract. New York: Raven Press; 1983.
10. Cho KR, Vogelstein B. Genetic alterations in the adenoma-carcinoma sequence. Cancer 1992;70:1727-31.
11. Cotran RS, Kumar V, Collins T. Pathologic basis of disease. 6 ed. Philadelphia: W B. Saunders; 1999.
12. Dani R. Gastroenterologia essencial. Rio de Janeiro: Guanabara; 1998.
13. Deguchi R, Takagi A, Kawata H, Inoko H, Miwa T. Association between CagA+ Helicobacter pylori infection and p53, bax and transforming growth factor-beta-RII gene mutations in gastric cancer patients. Int J Cancer 2001;91:481-5.
14. De Vita VT Jr, Hellman S, Rosenberg SA. Cancer - Principles and practice of oncology. 5. ed. Philadelphia: Lippincott-Raven; 1997. v.1.
15. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000;191:257-63.
16. Espinoza LA, Neto BJ, Casartelli C. Pathological and karyotypic abnormalities in advanced gastric carcinomas. Cancer Genet Cytogenet 1999;109:45-50.
17. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
18. Fraser AG, Sim R, Sankey EA, Dhillon AP, Pounder RE. Effect of eradiction of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther 1994;8:167-73.
19. Genta RM. Helicobacter pylori as a promotor of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol 1995;7:S25-S30.
20. Genta RM. Gastric atrophy and atrophic gastritis - nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998;12:17-23.
21. Guan XY, Fu SB, Xia JC, Fang Y, Sham JST, Du BD, Zhou H, Lu S, Wang BQ, Lin YZ, Liang Q, Lim XM, Ju B, Ning XM, Du JR, Lim P, Trent JM. Reccurent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genetic Cytogenetic 2000;123:27-34.
22. Hansson L, Nyren O, Hsing AW. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9.
23. Hao Y, Zhang J, Yi C, Qian W. Abnormal change of p53 gene in gastric and precancerous lesions and APC gene deletion in gastric carcinoma and near tissues. J Tongji Med Univ 1997;17:75-8.
24. Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997;108:26-34.
25. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992;33:429-31.
26. Igaki H, Sasaki H, Tachimori Y, Kato H, Watanabe H, Kimura T, Harada Y, Sugimura T, Terada M. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res 1995;55:3421-3.
27. INCA - Instituto Nacional do Câncer. Estimativa da incidência e mortalidade por câncer no Brasil. Rio de Janeiro; 2002.
28. Ito Y, Azuma T, Ito S, Suto H, Miyaji H, Yamazaki Y, Kato T, Kohli Y, Keida Y, Kuriyama M. Sequence analysis and clinical significance of the iceA gene from Helicobacter pylori strains in Japan. J Clin Microbiol 2000;38:483-8.
29. Jang TJ, Kim JR. Proliferation and apoptosis in gastric antral epithelial cells of patients infected with Helicobacter pylori. J Gastroenterol 2000;35:265-71.
30. Jass JR, Filipe MI. Variants of intestinal metaplasia associated with gastric carcinoma. A histochemical study. Histopathology 1997;3:191-9.
31. Kim YH, Kim NG, Lim JG, Park C, Kim H. Chromosomal alterations in paired gastric adenomas and carcinomas. Am J Pathol 2001;158:655-62.
32. Kitayama Y, Igarashi H, Sugimura H. Different vulnerability among chromosomes to numerical instability in gastric carcinogenesis: stage-dependent analysis by FISH with the use of microwave irradiation. Clin Cancer Res 2000;6:3139-46.
33. Kobayashi K, Okamoto T, Takayama S, Akiyama M, Ohono T, Yamada H. Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach. Eur J Cancer 2000;36:1113-9.
34. Kokkola A, Haapiainen R, Laxen F, Puolakkaninen P, Kivilalkso E, Virtamo J, Sipponen P. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow-up study. J Clin Pathol 1996;49:979-84.
35. Kono S, Hirohata T. Nutrition and stomach cancer. Cancer Causes Control 1996;7:41-55.
36. Koo SH, Kwon KC, Shin SY, Jeon YM, Park JW, Kim SH, Noh MS. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet 2000;117:97-103.
37. Kuipers EJ. Exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999;13:3-11.
38. Larramendy ML, El-Rifai W, Kokkola A, Puolakkainen P, Monni O, Salovaara R, Aarnio M, Knuutila S. Comparative genomic hybridization reveals differences in DNA copy number changes between sporadic gastric carcinomas and gastric carcinomas from patients with hereditary nonpoluposis colorectal cancer. Cancer Genet Cytogenet 1998;106:62-5.
39. Lynch DAF, Mapstone NP, Clarke AMT, Jackson P, Moayyedi R, Dixon MF, Quirke P, Axon ATR. Correlation between epithelial cell proliferation and histological grading in gastric mucosa. J Clin Pathol 1999;52:367-71.
40. Ma JL, You WC, Gail MH, Zhang L, Blot WJ, Chang YS, Jiang J. Liu WD, Hu YR, Brown LM, Xu GW, Fraumeni JF Jr. Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer. Int J Epidemiol 1998;27:570-3.
41. Maeta M, Saito H, Oka S, Tsujitani S, Ikeguchi N, Kaibara N. Mutated p53 in tumors, mutant p53 and p53-specific antibodies in the circulation in patients with gastric cancer. J Exp Clin Cancer Res 2000;19:489-95.
42. Ming SC, Hirota T. Malignant epithelial tumors of the stomach. In: Ming SC, Goldman H, editors. Pathology of the gastrointestinal tract. 2 ed. Baltimore: Williams & Wilkins; 1998. p.607-47.
43. Moss SF, Sordillo EM, Abdalla AM, Makarov V, Hanzely Z, Perez-Perez G, Blaser MJ, Holt PR. Increased gastric epithelial cell apoptosis associated with colonization with cagA+ Helicobacter pylori strains. Cancer Res 2001;61:1406-11.
44. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H. The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas. Cancer 2000;88:1894-902.
45. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearance. Jpn J Cancer Res 1968;69:930-5.
46. Nardone G, Staibano S, Rocco A, Mezza E, D'Armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Figura N, De Rosa G, Budillon G. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999;44:789-99.
47. Oashima H, Friesen M, Malaveille C, Brouet I, Hautefeuille A, Bartsch H. Formation of direct-acting genotoxic substances in nitrosated smoked fish and meat products: identification of simple phenolic precursors and phenyldiazonium ions as reactive products. Food Chem Toxicol 1989;27:193-200.
48. Okada K, Sugihara H, Bamba M, Bamba T, Hattori T. Sequential numerical changes of chromosomes 7 and 18 in diffuse-type stomach cancer cell lines: combined comparative genomica hybridization, fluorescence in situ hybridization and ploidy analyses. Cancer Genet Cytogenet 2000;118:99-107.
49. Park WS, Oh RR, Park JY, Shin MS, Lee HK, Lee SH, Yoo NJ, Lee JY. Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas. APMIS 2000;108:195-200.
50. Peek RM Jr, Thompson SA, Donahue JP, Tham KT, Atherton JC, Blaser MJ, Miller GG. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians 1998;110:531-44.
51. Peek RM, Blaser MJ, Mays DJ, Forsyth MH, Cover TI, Song SY, Krishnan U, Pietenpol JA. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res 1999;59:6124-31.
52. Poiemba C, Uandell DW, Huang Q, Little JB, Mellin W, Schmid KW, Bocker W, Dockhorn-Dworniczak B. Frequency and spectrum of p53 mutations in gastric cancer: a molecular genetic adn immunohistochemical study. Virchows Arch 1995;426:447-55.
53. Rudi J, Kuck D, Strand S, von Herbay A, Mariani SM, Krammer PH, Galle PR, Stremmei W. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest 1998;102:1506-14.
54. Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Latteri F, Valerio MR, Pantuso G, Morello V, Dardanoni G, Latteri MA, Colucci G, Tomasino RM, Gebbia N. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell' Italia Meridonale (GDIM) prospective study. Cancer 2001;92:294-302.
55. Safatle-Ribeiro A, Ribeiro U, Reynolds JC. Gastric stump cancer: What is the risk? Dig Dis 1998;16:159-68.
56. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J. Gains, losses and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999;24:299-305.
57. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994;144:511-7.
58. Sierra R, Munoz N, Pena AS. Antibodies to Helicobacter pylori and pepsinogen levels in children in Costa Rica. Cancer Epidemiol Biomark Prevent 1992;1:449-54.
59. Sipponen P, Kekki M, Siurala M. Precancerous conditions. In: Filipe MI, Jass JR, editors. Gastric cancer. Current problems in tumour pathology. London: Churchill Livingstone; 1985. p. 152-71.
60. Tahara E. Molecular mechanisms of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265-72.
61. Tahara E. Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection. Exp Toxicol Pathol 1998;50:375-8.
62. Takahashi Y, Shintaku K, Ishii Y, Asai S, Ishikawa K, Fujii M. Analysis of MYC and chromosome 8 copy number changes in gastrointestinal cancers by dual-color fluorescence in situ hybridization. Cancer Genet Cytogenet 1998;107:61-4.
63. Takahashi Y, Nagata T, Sataoshi A, Shintaku K, Eguchi T, Ishii Y, Fujii M, Ishikawa K. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and genechip p53 assay. Cancer Genet Cytogenet 2000;121:38-43.
64. Takano Y, Kato Y, van Diest PJ, Masuda M, Mitomi HC, Okayasu I. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 2000;156:585-94.
65. Tarasova NI, Rulong S, Oskarsson M. Cellular localization of met and its ligand hepatocyte growth factor/scatter factor in human stomach epithelium. Gastroenterology 1996;110:1125.
66. Tytgat G.N. Helicobacter pylori in man: problems to be solved. Dig Dis 1998;16:192-7.
67. van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, Boer W, Quint W. Clinical revelance of the cagA, vacA and iceA status of Helicobacter pylori. Gastroenterology 1998;115:58-66.
68. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 2000;35:111-5.
69. Yasui W, Oue N, Kuniyasu H, Ito R, Tahara E, Yokozaki H. Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 2001;4:113-21.
70. Ward MH, Sinha R, Heineman EF. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 1997;71:14-9.
71. Werner M, Becker KF, Keller GC, Hofler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001;127:207-16.